Latest Earnings
Equities
Stock Analysis
Stock Movers
Deals
Gainers And Losers
IPOs
Technology
Artificial Intelligence
Web Stories
Benzinga Inspire
Glenmark Pharmaceuticals
Why These Two Sister Pharma Stocks Are Plunging After Major Stake Sale
Glenmark Pharma will sell shares of Glenmark Life Sciences at ₹615 apiece, which is at a discount of around 1.8% to its last close of ₹626.20.
Glenmark Life Sciences Gains As Parent May Shed Stake Eyeing Lower Debt, US Plans
Why This Ashish Dhawan-Backed Pharma Stock Is Tanking Today
Why These Two Sister Pharma Stocks Are Plunging After Major Stake Sale
Glenmark Life Sciences Gains As Parent May Shed Stake Eyeing Lower Debt, US Plans
Why This Ashish Dhawan-Backed Pharma Stock Is Tanking Today
Suitors Line Up For Majority Stake In Glenmark Life Sciences
|
Parent Glenmark Pharmaceuticals reportedly aims to cut down on its debt burden by offloading a part of its 82.85% stake in Glenmark Life Sciences.
